CN108033931B - Synthesis method of N-Boc piperazine - Google Patents

Synthesis method of N-Boc piperazine Download PDF

Info

Publication number
CN108033931B
CN108033931B CN201711465168.XA CN201711465168A CN108033931B CN 108033931 B CN108033931 B CN 108033931B CN 201711465168 A CN201711465168 A CN 201711465168A CN 108033931 B CN108033931 B CN 108033931B
Authority
CN
China
Prior art keywords
boc
reaction
boc piperazine
diethanolamine
piperazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201711465168.XA
Other languages
Chinese (zh)
Other versions
CN108033931A (en
Inventor
梁辉
朱义胜
张庆涛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shandong Baoyuan Pharmaceutical Co ltd
Original Assignee
SHANDONG BOYUAN PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHANDONG BOYUAN PHARMACEUTICAL CO Ltd filed Critical SHANDONG BOYUAN PHARMACEUTICAL CO Ltd
Priority to CN201711465168.XA priority Critical patent/CN108033931B/en
Publication of CN108033931A publication Critical patent/CN108033931A/en
Application granted granted Critical
Publication of CN108033931B publication Critical patent/CN108033931B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205Radicals derived from carbonic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The invention discloses N-Boc piperazineA method for synthesizing oxazine. The method takes diethylaminoalcohol as a starting material, and N-Boc piperazine is synthesized through three steps of chlorination, Boc protection and aminolysis cyclization. The method has the advantages of easily available raw materials, mild reaction conditions, low product cost, high yield and high purity, and is suitable for industrial production.

Description

Synthesis method of N-Boc piperazine
Technical Field
The invention relates to a synthesis method of N-Boc piperazine, belonging to the technical field of organic synthesis.
Background
N-Boc piperazine, Chinese alias: n-tert-butoxycarbonylpiperazine, piperazine-1-carboxylic acid tert-butyl ester; molecular formula C9H18N2O2Molecular weight: 186.25. the chemical structural formula is as follows:
Figure GDA0002127801150000011
N-Boc piperazine belongs to piperazine monosubstituted compounds. The piperazine monosubstituted compounds become key intermediates in the synthesis of numerous drugs due to their special structures, such as: glucocorticoids such as palbociclib, ranolazine, dexamethasone, and the like. Therefore, the synthesized piperazine monosubstituted compound has very important pharmaceutical value and economic value.
The current method for synthesizing N-Boc piperazine mainly comprises the following two methods:
the method comprises the following steps: anhydrous piperazine is adopted to drop di-tert-butyl dicarbonate for selective reaction, and nitrogen at one end of piperazine is protected, so that amino at the other end reacts with another group. In the method, both ends of piperazine are connected with di-tert-butyl dicarbonate, and a large amount of water is needed for washing during purification, so that the yield of the product is reduced; the cost of three wastes treatment is increased, and the process has high raw material cost.
The second method comprises the following steps: starting from piperazine, carrying out a salt forming reaction with glacial acetic acid, adding di-tert-butyl dicarbonate for an acylation reaction, and finally extracting with toluene to obtain a crude product of N-tert-butoxycarbonylpiperazine; in the post-treatment, the unreacted raw materials and other impurities are removed by taking ethyl acetate as an extracting agent, and finally the qualified N-Boc piperazine product is obtained. Although the method improves the selectivity of N on piperazine, the method takes anhydrous piperazine as a main raw material, has high cost, and uses toluene, thereby posing a threat to the health of workers.
Disclosure of Invention
The invention overcomes the defects of the prior art and provides a synthetic method of N-Boc piperazine. The method takes diethanolamine as a starting material, and N-Boc piperazine is synthesized through three steps of chlorination, Boc protection and aminolysis cyclization. The method has the advantages of easily available raw materials, mild reaction conditions, low product cost, high yield and high purity, and is suitable for industrial production.
The technical scheme of the invention is as follows: a synthetic method of N-Boc piperazine is characterized by comprising the following steps:
1) diethanolamine (compound II) and a chlorinating agent react to generate bis (2-chloroethyl) amine (compound III);
2) bis (2-chloroethyl) amine and BOC anhydride react to generate bis (2-chloroethyl) carbamic acid tert-butyl ester (compound IV).
3) And (3) carrying out cyclization reaction on the bis (2-chloroethyl) carbamic acid tert-butyl ester and ammonia water to generate N-Boc piperazine (compound I).
The chlorinating agent in the step 1) is as follows: SOCl2、POCl3、PCl3、PCl5Etc., preferably SOCl2
The molar ratio of the chlorinating agent to the diethanol amine in the step 1) is 2-5:1, and preferably 3: 1.
The mole ratio of Boc anhydride to diethanolamine in the step 2) is 0.95-1.05:1, preferably 1: 1.
NH in ammonia water in the step 3)3The molar ratio to diethanolamine is from 2 to 4:1, preferably 3: 1.
Preferably, the step 1) is performed under reflux conditions.
Preferably, the step 2) is carried out under alkaline conditions.
Preferably, the ammonia water in the step 3) is in a dropwise adding mode, and the reaction temperature is 55-65 ℃.
The reaction equation is as follows:
Figure GDA0002127801150000021
further, the method specifically comprises the following steps:
1) dropping diethanolamine into thionyl chloride for reflux reaction for 3-5h, and cooling to below 10 ℃ after the reaction is finished;
2) adding purified water, adding inorganic base to adjust the pH value to be more than 10, then dropwise adding Boc anhydride, reacting at 10-30 ℃ for at least 12 hours after dropwise adding, and keeping the reaction system alkaline in the process;
3) heating to 55-65 ℃, and slowly dripping ammonia water; reacting for 2-5h at 55-65 ℃ after dripping, cooling to below 25 ℃, extracting with ethyl acetate, drying, concentrating under reduced pressure and evaporating ethyl acetate to obtain N-Boc piperazine.
The adding amount of the purified water in the step 2) is 2-3 times of the mass of the feed liquid in the step 1), the inorganic base is preferably sodium carbonate, and the reaction time is preferably 12-16 hours.
The ammonia water dropping time in the step 3) is preferably 2.5-3.5 h.
The invention has the beneficial effects that: the method has the advantages of simple and easily obtained raw materials, mild reaction conditions, low product cost, high yield (more than or equal to 93.5%), high purity and environmental friendliness, and is suitable for industrial production.
Detailed Description
Example 1:
1) 357g (3mol) of thionyl chloride is added into a 2000ml reaction bottle, 105g (1mol) of diethanolamine is added dropwise, and the temperature is raised and the reflux reaction is carried out for 4 hours; cooling to below 10 ℃, adding 1000ml of purified water, and stirring until heat is not released;
2) adding 636g (6mol) of sodium carbonate to dissolve, wherein the pH value is more than 10; controlling the temperature within 10-20 ℃, dripping 218g (1mol) of Boc anhydride, reacting for 12 hours at 25 ℃, and keeping the reaction system alkaline;
3) raising the temperature to 60 ℃, slowly dripping 182g (3mol) of ammonia water for about 3 hours; controlling the temperature to be 60 ℃ for reaction for 3h, then cooling to below 25 ℃, extracting reaction liquid (300 ml each time) by three times by using 900ml of ethyl acetate, drying an ethyl acetate layer by using anhydrous sodium sulphate, filtering, concentrating and evaporating the ethyl acetate under reduced pressure at below 60 ℃, and cooling to obtain 174.8g of N-Boc piperazine with the yield of 94.0% and the purity of 99.63%.
Example 2:
1) 327g (2.75mol) of thionyl chloride is added into a 2000ml reaction bottle, 105g (1mol) of diethanolamine is added dropwise, and the temperature is raised and the reflux is carried out for 4.5 h; cooling to below 10 ℃, adding 1000ml of purified water, and stirring until heat is not released;
2) 583g (5.5mol) of sodium carbonate are added to dissolve, the pH value is more than 10; controlling the temperature within 10-20 ℃, dripping 214g (0.98mol) of Boc anhydride, reacting for 14 hours at 25 ℃, and keeping the reaction system alkaline;
3) heating to 60 ℃, slowly dripping 170g (2.8mol) of ammonia water for about 3 hours; controlling the temperature to be 60 ℃ for reaction for 3.5h, reducing the temperature to be below 25 ℃, extracting reaction liquid by 900ml of ethyl acetate for three times, drying an ethyl acetate layer by using anhydrous sodium sulphate, filtering, concentrating under reduced pressure at the temperature of below 60 ℃ and evaporating the ethyl acetate to dryness, and cooling to obtain 174.5g of N-Boc piperazine, wherein the yield is 93.8 percent, and the purity is 99.72 percent.
Example 3:
1) adding 387g (3.25mol) of thionyl chloride into a 2000ml reaction bottle, dropwise adding 105g (1mol) of diethanolamine, and heating and refluxing for 3.5 h; cooling to below 10 ℃, adding 1000ml of purified water, and stirring until heat is not released;
2) 689g (6.5mol) of sodium carbonate are added to dissolve at a pH > 10. Controlling the temperature within 10-20 ℃, dripping 222g (1.02mol) of Boc anhydride, reacting for 12 hours at 25 ℃, and keeping the reaction system alkaline;
3) the temperature is raised to 60 ℃, 194g (3.2mol) of ammonia water is slowly dropped into the solution, and the dropping is finished for about 3 hours. Controlling the temperature to be 60 ℃ for reaction for 2.5h, reducing the temperature to be below 25 ℃, extracting reaction liquid by using 900ml of ethyl acetate for three times, drying an ethyl acetate layer by using anhydrous sodium sulphate, filtering, concentrating under reduced pressure at the temperature of below 60 ℃ and evaporating the ethyl acetate to dryness, and cooling to obtain 175.3g of N-Boc piperazine, wherein the yield is 94.3%, and the purity is 99.42%.

Claims (5)

1. A synthetic method of N-Boc piperazine is characterized by comprising the following steps:
1) diethanolamine and thionyl chloride react to generate di (2-chloroethyl) amine;
2) reacting bis (2-chloroethyl) amine with BOC anhydride to generate bis (2-chloroethyl) carbamic acid tert-butyl ester;
3) performing cyclization reaction on bis (2-chloroethyl) carbamic acid tert-butyl ester and ammonia water to generate N-Boc piperazine;
the method specifically comprises the following steps:
1) dropping diethanolamine into thionyl chloride for reflux reaction for 3-5h, and cooling to below 10 ℃ after the reaction is finished;
2) adding purified water, adding inorganic base sodium carbonate to adjust the pH value to be more than 10, then dropwise adding Boc anhydride, reacting at 10-30 ℃ for at least 12 hours after dropwise adding, and keeping the reaction system alkaline in the process;
3) heating to 55-65 ℃, slowly dripping ammonia water, and reacting for 2-5h at 55-65 ℃ after dripping; cooling to below 25 ℃, extracting with ethyl acetate, drying, decompressing, concentrating and evaporating the ethyl acetate to obtain the N-Boc piperazine.
2. The method for synthesizing N-Boc piperazine according to claim 1, wherein the molar ratio of thionyl chloride to diethanolamine in step 1) is 2.75-3.25: 1.
3. The method for synthesizing N-Boc piperazine according to claim 1, wherein the mole ratio of Boc anhydride to diethanolamine in step 2) is 0.95-1.05: 1.
4. The method for synthesizing N-Boc piperazine according to claim 1, wherein NH is added into ammonia water in step 3)3The molar ratio of the compound to the diethanol amine is 2-4: 1.
5. The method for synthesizing N-Boc piperazine according to claim 1, wherein the amount of the purified water in the step 2) is 2-3 times of the mass of the feed liquid in the step 1), the inorganic base is sodium carbonate, and the reaction time is 12-16 hours.
CN201711465168.XA 2017-12-28 2017-12-28 Synthesis method of N-Boc piperazine Active CN108033931B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711465168.XA CN108033931B (en) 2017-12-28 2017-12-28 Synthesis method of N-Boc piperazine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711465168.XA CN108033931B (en) 2017-12-28 2017-12-28 Synthesis method of N-Boc piperazine

Publications (2)

Publication Number Publication Date
CN108033931A CN108033931A (en) 2018-05-15
CN108033931B true CN108033931B (en) 2020-03-10

Family

ID=62097831

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711465168.XA Active CN108033931B (en) 2017-12-28 2017-12-28 Synthesis method of N-Boc piperazine

Country Status (1)

Country Link
CN (1) CN108033931B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118125995A (en) * 2024-02-29 2024-06-04 南昌大学抚州医学院 Synthesis method of 1- (2-methoxyphenyl) piperazine hydrochloride

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102153526A (en) * 2010-12-20 2011-08-17 金坛市爱特生物科技有限公司 Synthesis method of N-tert-butoxycarbonylpiperazine
WO2013106535A1 (en) * 2012-01-10 2013-07-18 Nimbus Iris, Inc. Irak inhibitors and uses thereof
CN103224476A (en) * 2013-05-25 2013-07-31 上高县瑞雅精细化工有限公司 New process for preparing 1-[2-(2-hydroxyethoxy)ethyl]piperazine through diethanolamine method
WO2017147328A1 (en) * 2016-02-23 2017-08-31 Portola Pharmaceuticals, Inc. Compounds for binding proprotein convertase subtilisin/kexin type 9 (pcsk9)
CN107501209A (en) * 2016-06-14 2017-12-22 江苏吉贝尔药业股份有限公司 The carboxylic acid tert-butyl ester synthetic method of 4 [2 (the bromobenzene sulfydryl of 2 methyl 4) phenyl] piperazine 1

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102153526A (en) * 2010-12-20 2011-08-17 金坛市爱特生物科技有限公司 Synthesis method of N-tert-butoxycarbonylpiperazine
WO2013106535A1 (en) * 2012-01-10 2013-07-18 Nimbus Iris, Inc. Irak inhibitors and uses thereof
CN103224476A (en) * 2013-05-25 2013-07-31 上高县瑞雅精细化工有限公司 New process for preparing 1-[2-(2-hydroxyethoxy)ethyl]piperazine through diethanolamine method
WO2017147328A1 (en) * 2016-02-23 2017-08-31 Portola Pharmaceuticals, Inc. Compounds for binding proprotein convertase subtilisin/kexin type 9 (pcsk9)
CN107501209A (en) * 2016-06-14 2017-12-22 江苏吉贝尔药业股份有限公司 The carboxylic acid tert-butyl ester synthetic method of 4 [2 (the bromobenzene sulfydryl of 2 methyl 4) phenyl] piperazine 1

Also Published As

Publication number Publication date
CN108033931A (en) 2018-05-15

Similar Documents

Publication Publication Date Title
WO2015198505A1 (en) Method for producing synthetic pentapeptide
CN108033931B (en) Synthesis method of N-Boc piperazine
CN105237496A (en) A new method for synthesizing N-tert-butoxycarbonylpiperazine
MX2008000961A (en) Method for preparing 4beta-amino-4demethyl-4-desoxypodophyllotoxin.
CN110511159B (en) Synthesis method of benserazide hydrochloride
CN111072660B (en) Simple preparation method of rilibatan
CN104703967B (en) The process for purification of fluvoxamine free alkali and the preparation method of the high-purity fluvoxamine maleate using which
US9790170B2 (en) Method for preparing lacosamide
CN112194585B (en) Synthetic method of bromhexine hydrochloride
CN111269144A (en) Preparation method of aminobenzonitrile
CN107673984B (en) Preparation method of levetiracetam key intermediate (S) -2-aminobutanamide salt
CN114591187B (en) Preparation method of 1,3-bis (tris (hydroxymethyl) methylamino) propane
CN113105386B (en) Industrialized preparation method of ropivacaine hydrochloride monohydrate
CN111646991B (en) Preparation method of avibactam sodium intermediate
CN111004141B (en) New method for synthesizing nintedanib intermediate 2-chloro-N-methyl-N- (4-nitrophenyl) acetamide
CN112940022B (en) Preparation method of dimethylamine borane
CN113307767A (en) Synthetic method of lenvatinib
CN106316985B (en) Beta type efficient vortioxetine hydrobromide crystal transformation method
EP2234975B1 (en) Process for producing pipecolic-2-acid-2 ',6'-xylidide useful as an intermediate for the preparation of local anesthetics
CN109535025B (en) Preparation method of Evonib intermediate 3, 3-difluorocyclobutylamine hydrochloride
CN110698381A (en) Method for synthesizing N- (benzyloxycarbonyl) succinimide by one-pot two-phase method
CN114853619B (en) Preparation method of N-methyltyramine hydrochloride suitable for industrial production
CN114315773B (en) Piperazine compound and preparation method thereof
CN214612250U (en) Synthesis system of chiral amine
CN115536610B (en) Preparation method of vothixetine

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CP03 Change of name, title or address
CP03 Change of name, title or address

Address after: 251400 No. 12, Taixing East Street, Jibei Economic Development Zone, Jiyang District, Jinan City, Shandong Province

Patentee after: Shandong Baoyuan Pharmaceutical Co.,Ltd.

Address before: Strong in Jiyang County of Ji'nan City, 251400 North Street, Shandong Province Economic Development Zone

Patentee before: SHANDONG BOYUAN PHARMACEUTICAL Co.,Ltd.